The Texas A&M biomedical engineering department's scaffolded, inquiry-based biomimicry course has been shown to improve student engagement and imagination competency. Students learn to use nature as a model to solve engineering problems, resulting in breakthroughs in clinical impact and innovation.
Microalgae are transformed into functionalized composite bioproducts for precision diagnosis, targeted therapy, and integrated theranostics. They offer exceptional biological properties for biomedical engineering, including molecular loading, active movement, and intense autofluorescence for imaging applications.
The new joint department combines expertise in medical devices, neuroengineering, imaging science, and more to advance biomedical research and translate discoveries into meaningful health advances. The partnership aims to accelerate the translation of discoveries into improvements in human health.
Dr. Yangzhi Zhu has been awarded a prestigious Career Development Award from the American Heart Association to support his research in translational biosensing and organ health assessment. The award aims to develop innovative sensing strategies for improving donor organ condition and supporting better clinical care.
A recent study published by Pennington Biomedical Research Center has shed light on the key drivers of chronic disease in Assumption Parish. The research found that residents with lower education levels are more likely to suffer from high blood pressure, high cholesterol, and obesity. This correlation suggests a strong link between edu...
The Terasaki Institute for Biomedical Innovation and UCLA Technology Development Group will co-curate an Advanced Organ and Tissue Repair (AToR) session at LABEST, featuring leading experts in regenerative medicine. The session aims to accelerate the translation of breakthrough technologies into real-world clinical solutions.
UT San Antonio has emerged as a unified academic powerhouse, with strong performances in the Blue Ridge Institute for Medical Research rankings. The university has climbed 5 spots to No. 64 among 2,702 institutions, with $147,098,904 in NIH funding, reflecting its commitment to biomedical discovery and research excellence.
The partnership aims to accelerate biomedical innovation through joint research programs, faculty collaboration, and expanded student training opportunities. Researchers will have access to shared laboratory infrastructure, reciprocal faculty affiliations, and joint grant proposals.
The Greaux Healthy initiative, launched by Pennington Biomedical Research Center, aims to prevent and treat childhood obesity in Louisiana. Studies show that childhood obesity is a national healthcare crisis in Louisiana, with over 1 in 3 children living with overweight or obesity.
A Pennington Biomedical researcher published an editorial on the benefits of fruit intake for vascular health, citing a study on increasing fruit intake with avocados and mangos. The findings suggest that diets rich in fruits can improve nutrient status and health outcomes, aligning with the goals of the Food Is Medicine initiative.
The MOH–NUS Postgraduate Fellowship in Biomedical Ethics aims to equip healthcare professionals with knowledge and understanding of biomedical ethics, ethical analysis and reasoning. The first awardee, Ms Kwek Shi Qi, will conduct a research project to map barriers and drivers for nurses mediating ethical conflicts in frontline work.
Developing a lifesaving device that can stop fatal blood loss in seconds, researchers at Texas A&M University have made significant breakthroughs. By using clay minerals and nano-silicate particles, the team has created injectable hemostatic bandages that reduce bleeding time by nearly 70%.
Professor Michael L. King has been elected to the National Academy of Engineering for his seminal contributions to transport phenomena and biomedical engineering. His work has deepened fundamental understanding of particle transport, adhesion, and aerosol behavior in biological systems, informing advances across biomedical applications...
Dr. Catherine Prater's research project aims to improve prediction models and uncover metabolic markers that explain individual differences in weight gain. She will use machine learning techniques to train and test prediction models using existing clinical trial data.
Large Language Models pose both benefits and challenges to academic integrity in biomedical research, enhancing efficiency and quality but also promoting misconduct and bias. To address these issues, this paper proposes solutions centered on ten core dimensions.
A Virginia Tech scientist emphasizes the importance of preserving the nation's ability to turn discovery into life-saving therapies. He argues that strong transparency and careful oversight are key to making the technology-transfer ecosystem work, and that abandoning it could have unintended consequences.
The Vilcek Foundation has awarded $9.6 million to 14 individuals from 12 countries for their contributions to the arts and sciences in the US. This year's prize winners include scientists, artists, and fashion designers who have made significant advancements in their fields.
Dr. Candida Rebello's five-year NIH grant will explore lifestyle strategies to reduce excess body fat and declining muscle mass in older adults with obesity. The study aims to protect skeletal muscle health, independence, and quality of life for this rapidly growing population.
The new NIH policy on research using human fetal tissue could undermine the development of life-saving therapies for various diseases. The ISSCR urges NIH to reconsider its decision and engage constructively with the scientific community to support biomedical research.
A study analyzing millions of biomedical and life science articles reveals that female-authored articles spend longer under review than comparable male-authored articles across most fields. The disparity underscores the ongoing issue of women's underrepresentation in academia, particularly in STEMM fields.
BioPathNet is an AI method that analyzes large biomedical knowledge graphs to identify hidden connections between genes, diseases, and drugs. The model proposes hypotheses that can be tested experimentally or clinically, providing a hypothesis-generating tool for researchers.
The DASH Diet, developed at Pennington Biomedical Research Center, has been ranked as the best heart-healthy diet and second-best overall by US News & World Report. The diet's focus on fiber, heart-healthy minerals, and whole grains helps lower blood pressure and reduce cardiovascular risk.
Pennington Biomedical researchers investigated competing body weight regulation models, analyzing the interaction of energy intake and expenditure. The study highlights the need to test state-of-the-art technology and could help explain why losing weight is challenging for some individuals.
Dr. Gang Hu, a leading expert in chronic disease epidemiology, has been appointed to the NIH Reproductive, Perinatal and Pediatric Health Review Group. He will evaluate studies on reproductive, perinatal, and pediatric health, with a focus on lifestyle factors and their impact on chronic diseases.
Dr. Jennifer Rood, Associate Executive Director for Cores and Resources, takes on interim leadership role at Pennington Biomedical Research Center while an international search for the next full-time Executive Director is underway. She brings over 30 years of experience in obesity and chronic disease research.
Jason McCarthy, a renowned biomedical researcher, has been promoted to professor at the Masonic Medical Research Institute. He has made significant contributions to medical research since joining the organization in 2018.
Philip R. Troyk, director of the Pritzker Institute of Biomedical Science and Engineering at Illinois Tech, has been elected as a Fellow of the National Academy of Inventors for his groundbreaking work on neuroprosthetic devices, including an implanted cortical visual prosthesis that provides artificial vision to individuals with profo...
A study analyzing 1000 biomedical articles found that almost 1 in 5 'recent' references are at least 10 years old, suggesting the term is used more as a narrative device than a measure of time. Citation patterns varied across medical specialties, with some fields citing older references than others.
The Pew Charitable Trusts has funded seven new biomedical research collaborations, bringing together 14 renowned scientists to tackle pressing problems in human health. These interdisciplinary projects will accelerate discoveries and advance understanding of human biology and disease.
Pennington Biomedical Research Center launched its first international scientific symposium in Riyadh, Saudi Arabia, exceeding expectations with distinguished audience engagement and new institutional contacts.
Researchers at Virginia Tech's Fralin Biomedical Research Institute are developing tools to gather high-quality brain function data during infancy, enabling studies on brain development and potential risk factors for disorders. The study aims to capture real-time brain activity during natural social interactions.
Biomedical researchers recommend diversifying funding sources, pursuing earlier licensing and commercialization, and fostering international collaborations. The US drug discovery landscape is at risk due to federal funding cuts, and alternative approaches are needed to ensure continued progress.
Dr. Corby Martin has been appointed as the Associate Executive Director for Scientific Education at Pennington Biomedical Research Center. He will provide leadership for key programs such as the T32 Postdoctoral Training Program, the Pennington Scientific Symposium and the Bray Obesity Symposium.
A recent study published in Obesity found a direct relationship between obesity severity and the likelihood of disease burden in the US population. The researchers discovered that higher BMI levels were associated with increased odds for various cardiometabolic conditions, including diabetes, hypertension, and kidney disease.
Dr. Leanne Redman joins the Charles Perkins Centre to lead research on obesity, diet, and exercise, building on her extensive experience in women's health issues and translational research. With over 300 publications and numerous awards, she will expand the centre's impact on global health.
Researchers Andrew Gewirtz and Lanying Du from the Institute for Biomedical Sciences at Georgia State University have been recognized as Highly Cited Researchers in 2025. They are among the top 1% of globally impactful researchers, with highly cited papers in multiple fields.
Four researchers from LSU's Pennington Biomedical Research Center have been named among the world's most highly cited scientists. Dr. Steven Heymsfield, Dr. Peter Katzmarzyk, Dr. Eric Ravussin and Dr. Donna Ryan are recognized for their significant and broad influence in their respective fields.
Cynthia Nau Cornelissen has received nearly $7 million in federal grants to combat sexually transmitted infections (STIs), particularly gonorrhea. The researcher will study the human-specific pathogen Neisseria gonorrhoeae and develop vaccines and therapeutics using innovative approaches.
A new study from Texas Biomedical Research Institute found that low-dose THC significantly reduced side effects and inflammation caused by HIV and antiretroviral therapy. The treatment also increased serotonin levels, lowered cholesterol and toxic bile acids, and improved cardiovascular health.
A new gene editing technique, P3a mutagenesis, achieves near 100% success in creating precise DNA mutations. This method simplifies protein engineering, accelerating biomedical research and reducing costs.
The Louisiana ECHO program, which focuses on pre-, peri- and postnatal outcomes, obesity, and other areas, will continue its efforts to expand access to clinical trials for Louisiana children. The grant renewal supports the collaboration between researchers from Pennington Biomedical and Ochsner Health System, as well as two free-stand...
Pennington Biomedical researchers will participate in numerous panels and presentations during the conference, sharing their latest findings on obesity treatment and prevention. The institution is well-represented at the event, with faculty members among the experts leading courses, presentations, and speaker panels.
The National Institutes of Health has renewed Pennington Biomedical's Metabolic Basis of Disease Center for five years, providing $2.2M per year to support research on the mechanisms of metabolic health. The center aims to address the obesity epidemic and its related illnesses.
The acquisition unifies genetics and stem cell research expertise to accelerate discovery and translate science into therapies. Researchers will gain access to advanced platforms, including the NYSCF Global Stem Cell Array, to study disease mechanisms and test treatments.
Christopher Chen, a renowned biomedical engineer, has been elected to the National Academy of Medicine for his groundbreaking contributions to cell and tissue engineering. His research may lead to lifesaving new treatments for disease, including heart attack cures and organ repairs.
Researchers at Binghamton University created a new technique for engineering vascular systems using nanotubes, which improved blood distribution and supplied cells with nutrition and oxygen. The technology has potential applications in treating tumors or neurodegenerative diseases.
The four-day training program equipped postdoctoral fellows with state-of-the-art methods for clinical research in obesity, metabolism and nutrition. Participants deepened their skills in gold-standard methodologies crucial for advancing clinical and translational research.
The bregr R package streamlines the process of analyzing large-scale biomedical data by automating model fitting, extracting tidy results, and providing publication-quality visualizations. This results in enhanced efficiency and scalability for researchers, while maintaining reproducibility and accuracy.
Published by Far Publishing Company, Current Pharmaceutical Analysis (CPA) provides a platform for researchers to share their latest findings. The journal focuses on drug discovery to clinical application, aiming to advance every aspect of pharmaceutical science.
Professor Lim Chwee Teck, Director of NUS iHealthtech, has been elected an International Fellow of the Royal Academy of Engineering for his pioneering research in biomedical engineering and wearable technologies. His work on disease diagnosis and therapy has translated into impactful healthcare solutions through start-ups.
The 2025 Childhood Obesity Conference, hosted by Pennington Biomedical's Greaux Health initiative, aims to educate healthcare providers and promote healthier futures for Louisiana's children through cutting-edge research and evidence-based strategies. Participants can earn up to 7.5 CMEs and gain practical tools to support healthier fu...
Dr. Steven B. Heymsfield joins an elite group of scholars recognized for advancing knowledge and transforming their fields. He has authored over 1,300 scientific publications with nearly 79,000 citations, placing him among the top 500 most-cited researchers globally.
The Korea University College of Medicine hosted the K-CLUB International Symposium to promote interdisciplinary collaboration and address global health challenges. Distinguished global scholars explored the future of human health from diverse perspectives, including clinical care, biomedical convergence, and health policy.
Dr. Michael J. Welsh has advanced understanding and treatment of cystic fibrosis through his pioneering research on chloride channels and CFTR function. He has developed new therapies, including a porcine model of CF, leading to improved treatments for 90% of people with the disease.
A recent study by Pennington Biomedical researchers found that pregnant women with metabolically unhealthy obesity were twice as likely to develop gestational diabetes and had more body fat at birth. Despite lower weight gain, these mothers' metabolic health played a crucial role in their baby's development.
The Pennington Biomedical Research Center has opened a new Endocrinology and Diabetes Clinic in Baton Rouge, providing specialized care for patients managing diabetes and endocrine disorders. The clinic is led by Dr. Timothy Gilbert, who brings nearly 20 years of private practice experience to the region.
The Pew Charitable Trusts has awarded four-year grants to 22 early-career scientists, enabling them to uncover fundamental insights about human health and disease. The selected researchers will explore various topics, including gut bacteria's role in metabolic diseases and the development of the human brain.
Dr. Nick Burton, a researcher at Van Andel Institute, has been awarded the Pew Charitable Trusts' prestigious Pew Scholar award in Biomedical Sciences. He will investigate how environmental factors influence health, including exposure to stress and microbes, and explore new Type 2 diabetes treatments.
Researchers have discovered a way to selectively create links between sugar molecules, enabling precise control over the stereochemistry of oligosaccharides. This breakthrough could open up new avenues of biomedical research into these versatile molecules, providing access to previously difficult-to-construct oligosaccharides.
The Pew Charitable Trusts has funded 10 postdoctoral Latin American researchers for two years of biomedical science research in the US. They are exploring topics like brain tumor evolution, immune cell function, and nervous system repair.